Advancing Automated Bench Top Systems for Cell Therapy: Towards Future MTP Enabled Hollow Fiber Transduction Platforms

Personalised cell therapy demands modular automation at every scale.
This presentation dives into how benchtop systems for CAR‑T production can be designed as MTP‑ready process equipment assemblies. The challenge is not only automation—but GMP compliance, audit trails and batch orchestration.

Engineers see how MTP enables separation between equipment execution and process orchestration, while supporting strict regulatory requirements such as CFR 21 Part 11. The architecture balances flexibility with control—critical in advanced therapies.

If you work with small‑scale, high‑value manufacturing where processes evolve fast, this talk shows how modular automation supports both innovation and compliance.